Johannes Ruige

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

Daniela Lamers, Susanne Famulla, Nina Wronkowitz et al. · Diabetes · 2011 · 578 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes

Stefan Lehr, Sonja Hartwig, Daniela Lamers et al. · Molecular & Cellular Proteomics · 2011 · 239 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction

Sabrina Greulich, Bujar Maxhera, Guy Vandenplas et al. · Circulation · 2012 · 201 citations · Full text

Life Sciences, Cardiology, Physiology +17